Detalles de la búsqueda
1.
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.
Lancet Oncol
; 18(7): 946-957, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28549783
2.
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group.
Eur J Cancer
; 172: 264-275, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35809374
3.
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group.
J Clin Oncol
; 40(35): 4107-4118, 2022 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35839426
4.
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.
Clin Cancer Res
; 27(8): 2179-2189, 2021 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33504555
5.
Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO.
PLoS One
; 15(7): e0236115, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32697811
6.
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.
J Clin Oncol
; 38(19): 2160-2169, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32343642
7.
Comparison of bead array and glass nanoreactor multi-analyte platforms for the evaluation of CNS and peripheral inflammatory markers during HIV infection.
J Immunol Methods
; 465: 7-12, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30468733
8.
MPDA: microarray pooled DNA analyzer.
BMC Bioinformatics
; 9: 196, 2008 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18412951
9.
Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931.
Front Immunol
; 9: 1641, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30046297
10.
A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931.
Front Immunol
; 9: 1355, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29967609
11.
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group.
Clin Cancer Res
; 24(1): 189-196, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28972044
12.
Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma.
PLoS One
; 12(3): e0172632, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28296891
13.
3-amino thioacridone inhibits DNA synthesis and induce DNA damage in T-cell acute lymphoblastic leukemia (T-ALL) in a p16-dependent manner.
J Exp Ther Oncol
; 4(3): 223-37, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15724842
14.
Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodynia.
PLoS One
; 9(2): e87210, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24520328
15.
Absence of MGST1 mRNA and protein expression in human neuroblastoma cell lines and primary tissue.
Free Radic Biol Med
; 69: 167-71, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24486338
16.
Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth.
PLoS One
; 9(2): e88219, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24505435
17.
High expression of CAI2, a 9p21-embedded long noncoding RNA, contributes to advanced-stage neuroblastoma.
Cancer Res
; 74(14): 3753-63, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25028366
18.
Renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy.
J Exp Clin Cancer Res
; 32: 57, 2013 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23958461
19.
microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma.
Cancer Res
; 70(20): 7841-50, 2010 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20805302
20.
Inactivation of SHIP1 in T-cell acute lymphoblastic leukemia due to mutation and extensive alternative splicing.
Leuk Res
; 33(11): 1562-6, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19473701